Moderna, Inc. (MRNA.MX)
Develops messenger RNA vaccines and therapies for infectious diseases and cancer.
940.00-0.03%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+82.5%
The outlook
Moderna is trading near the midpoint of its 52-week range with a mixed price trend relative to its moving averages. Analyst coverage shows a neutral lean overall. The stock is essentially flat today.
What’s behind the score
Price trendMixed vs its moving averages
52-week range51% of the way from its 52-week low to high
Market cap
$372.98B
52-wk high
1,451.38
52-wk low
414.00
50-day avg
1,023.89
200-day avg
790.67
Trailing P/E
—